Dynamics and modulation of metabotropic glutamate receptors

Current Opinion in Pharmacology

Volumn 20, Issue , 2015, Pages 95-101

  Rondard, Philippe ^a,b   Pin, Jean Philippe ^a,b  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; LIGAND;

ALLOSTERISM; BINDING AFFINITY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; LIGAND BINDING; MOLECULAR DYNAMICS; PROTEIN DOMAIN; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION; CENTRAL NERVOUS SYSTEM; DRUG DESIGN; DRUG EFFECTS; MENTAL DISORDERS; METABOLISM; MOLECULARLY TARGETED THERAPY; NERVOUS SYSTEM DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ALLOSTERIC REGULATION; CENTRAL NERVOUS SYSTEM; DRUG DESIGN; GLUTAMIC ACID; HUMANS; LIGANDS; MENTAL DISORDERS; MOLECULAR TARGETED THERAPY; NERVOUS SYSTEM DISEASES; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPTIC TRANSMISSION;

EID: 84919681704     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.12.001     Document Type: Review

References (57)

1. Conn P, Pin JP: Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997, 37:205-237.
2. Niswender CM, Conn PJ: Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010, 50:295-322.
3. Gregory KJ, Noetzel MJ, Niswender CM: Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders. Prog Mol Biol Transl Sci 2013, 115:61-121.
4. Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ, Ramos FJ, Cornish K, He Y, Paulding C et al.: Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 2011, 3:64ra1.
5. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA et al.: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med 2007, 13:1102-1107.
6. Kniazeff J, Prézeau L, Rondard P, Pin JP, Goudet C: Dimers and beyond: the functional puzzles of class C GPCRs. Pharmacol Ther 2011, 130:9-25.
7. El Moustaine D, Granier S, Doumazane E, Scholler P, Rahmeh R, Bron P, Mouillac B, Banères JL, Rondard P, Pin JP: Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling. Proc Natl Acad Sci U S A 2012, 109 :16342-16347.
8. Doumazane E, Scholler P, Fabre L, Zwier JM, Trinquet E, Pin JP, Rondard P: A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors. FASEB J 2011, 25:66-77.
9. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, Bazin H, Tinel N, Durroux T, Prézeau L, Trinquet E, Pin JP: Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 2008, 5:561-567.
10. Yin S, Noetzel MJ, Johnson KA, Zamorano R, Jalan-Sakrikar N, Gregory KJ, Conn PJ, Niswender CM: Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS. J Neurosci 2014, 34:79-94.
11. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K: Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 2000, 407:971-977.
12. Muto T, Tsuchiya D, Morikawa K, Jingami H: Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc Natl Acad Sci U S A 2007, 104:3759-3764.
13. Rondard P, Liu J, Huang S, Malhaire F, Vol C, Pinault A, Labesse G, Pin JP: Coupling of agonist binding to effector domain activation in metabotropic glutamate-like receptors. J Biol Chem 2006, 281:24653-24661.
14. Rondard P, Goudet C, Kniazeff J, Pin JP, Prézeau L: The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors. Neuropharmacology 2011, 60:82-92.
15. 3+. Proc Natl Acad Sci U S A 2002, 99:2660-2665.
16. Doré AS, Okrasa K, Patel JC, Serrano-Vega M, Bennett K, Cooke RM, Errey JC, Jazayeri A, Khan S, Tehan B et al.: Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature 2014, 511:557-562.
17. Wu H, Wang C, Gregory KJ, Han GW, Cho HP, Xia Y, Niswender CM, Katritch V, Meiler J, Cherezov V, Conn PJ, Stevens RC: Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science 2014, 344 :58-64.
18. Ballesteros J, Weinstein H: Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors. Methods Neurosci 1995, 25:366-428.
19. Pin JP, Galvez T, Prézeau L: Evolution, structure and activation mechanism of family 3/C G-protein coupled receptors. Pharmacol Ther 2003, 98:325-354.
20. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM: Molecular signatures of G-protein-coupled receptors. Nature 2013, 494:185-194.
21. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI et al.: Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012, 485:327-332.
22. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC: High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
23. Ruprecht JJ, Mielke T, Vogel R, Villa C, Schertler GF: Electron crystallography reveals the structure of metarhodopsin I. EMBO J 2004, 23:3609-3620.
24. Xue L et al.: Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer. Nat Chem Biol 2015 http://dx.doi.org/10.1038/NCHEMBIO.1711.
25. Guo W, Shi L, Filizola M, Weinstein H, Javitch JA: Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci U S A 2005, 102:17495-17500.
26. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S: Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 2012, 485:321-326.
27. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC et al.: Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330 :1066-1071.
28. Bessis AS, Rondard P, Gaven F, Brabet I, Triballeau N, Prézeau L, Acher F, Pin JP: Closure of the Venus Flytrap module of mGlu8 receptor and the activation process: insights from mutations converting antagonists into agonists. Proc Natl Acad Sci U S A 2002, 99:11097-11102.
29. Kniazeff J, Saintot PP, Goudet C, Liu J, Charnet A, Guillon G, Pin JP: Locking the dimeric GABA(B) G-protein-coupled receptor in its active state. J Neurosci 2004, 24:370-377.
30. Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prézeau L, Pin JP: Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol 2004, 11:706-713.
31. Huang S, Cao J, Jiang M, Labesse G, Liu J, Pin JP, Rondard P: Interdomain movements in metabotropic glutamate receptor activation. Proc Natl Acad Sci U S A 2011, 108:15480-15485.
32. Hlavackova V, Goudet C, Kniazeff J, Zikova A, Maurel D, Vol C, Trojanova J, Prézeau L, Pin JP, Blahos J: Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J 2005, 24 :499-509.
33. Doumazane E, Scholler P, Fabre L, Zwier JM, Trinquet E, Pin JP, Rondard P: Illuminating the activation mechanisms and allosteric properties of metabotropic glutamate receptors. Proc Natl Acad Sci U S A 2013, 110:E1416-E1425.
34. Olofsson L, Felekyan S, Doumazane E, Scholler P, Fabre L, Zwier JM, Rondard P, Seidel AM, Pin JP, Margeat E: Fine tuning of sub-millisecond conformational dynamics controls metabotropic glutamate receptors agonist efficacy. Nat Commun 2014, 5:5206.
35. Hlavackova V, Zabel U, Frankova D, Bätz J, Hoffmann C, Prézeau L, Pin JP, Blahos J, Lohse MJ: Sequential inter- and intra-subunit rearrangements during activation of dimeric metabotropic glutamate receptor 1. Sci Signal 2012, 5:ra59.
36. Tateyama M, Kubo Y: Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1alpha. Proc Natl Acad Sci U S A 2006, 103:1124-1128.
37. Marcaggi P, Mutoh H, Dimitrov D, Beato M, Knopfel T: Optical measurement of mGluR1 conformational changes reveals fast activation, slow deactivation, and sensitization. Proc Natl Acad Sci U S A 2009, 106:11388-11393.
38. Rosenbaum DM, Rasmussen SG, Kobilka BK: The structure and function of G-protein-coupled receptors. Nature 2009, 459:356-363.
39. Parmentier ML, Prézeau L, Bockaert J, Pin JP: A model for the functioning of family 3 GPCRs. Trends Pharmacol Sci 2002, 23:268-274.
40. Conn PJ, Lindsley CW, Meiler J, Niswender CM: Opportunities and challenges in the discovery allosteric modulators of GPCRs for treating CNS disorders. Nat Rev Drug Discov 2014, 13:692-708.
41. Goudet C, Vilar B, Courtiol T, Deltheil T, Bessiron T, Brabet I, Oueslati N, Rigault D, Bertrand HO, McLean H et al.: A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. FASEB J 2012, 26:1682-1693.
42. Sheffler DJ, Gregory KJ, Rook JM, Conn PJ: Allosteric modulation of metabotropic glutamate receptors. Adv Pharmacol 2011, 62:37-77.
43. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB: Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 2007, 320:1-13.
44. Nordström KJ, Sallman Almén M, Edstam MM, Fredriksson R, Schiöth HB: Independent HHsearch, Needleman-Wunsch-based, and motif analyses reveal the overall hierarchy for most of the G protein-coupled receptor families. Mol Biol Evol 2011, 28:2471-2480.
45. Wood MR, Hopkins CR, Brogan JT, Conn PJ, Lindsley CW: Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry 2011, 50:2403-2410.
46. Rovira X, Malhaire F, Scholler P, Rodrigo de Losada J, Gonzalez-Bulnes P, Llebaria A, Pin JP, Giraldo J, Goudet C: Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors. FASEB J 2015 http://dx.doi.org/10.1096/fj.14-257287.
47. Katritch V, Fenalti G, Abola EE, Roth BL, Cherezov V, Stevens RC: Allosteric sodium in class A GPCR signaling. Trends Biochem Sci 2014, 39:233-244.
48. Jiang JY, Nagaraju M, Meyer RC, Zhang L, Hamelberg D, Hall RA, Brown EM, Conn PJ, Yang JJ: Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1alpha. J Biol Chem 2014, 289:1649-1661.
49. Kuang D, Hampson DR: Ion dependence of ligand binding to metabotropic glutamate receptors. Biochem Biophys Res Commun 2006, 345:1-6.
50. Ullmer C, Zoffmann S, Bohrmann B, Matile H, Lindemann L, Flor P, Malherbe P: Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7. Br J Pharmacol 2012, 167:1448-1466.
51. Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G et al.: Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452:93-97.
52. Kruse AC, Ring AM, Manglik A, Hu J, Hu K, Eitel K, Hübner H, Pardon E, Valant C, Sexton PM et al.: Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 2013, 504:101-106.
53. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, Mathiesen JM, Shah ST, Lyons JA, Caffrey M, Gellman SH, Steyaert J, Skiniotis G, Weis WI, Sunahara RK, Kobilka BK: Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011, 477:549-555.
54. Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, Kobilka BK: Adrenaline-activated structure of beta2-adrenoceptor stabilized by an engineered nanobody. Nature 2013, 502:575-579.
55. Mujic-Delic A, de Wit RH, Verkaar F, Smit MJ: GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics. Trends Pharmacol Sci 2014, 35:247-255.
56. Levitz J, Pantoja C, Gaub B, Janovjak H, Reiner A, Hoagland A, Schoppik D, Kane B, Stawski P, Schier AF, Trauner D, Isacoff EY: Optical control of metabotropic glutamate receptors. Nat Neurosci 2013, 16:507-516.
57. Pittolo S, Gómez-Santacana X, Eckelt K, Rovira X, Dalton J, Goudet C, Pin JP, Llobet A, Giraldo J, Llebaria A, Gorostiza P: An allosteric modulator to control endogeneous G proteincoupled receptors with light. Nat Chem Biol 2014, 10:813-815.